Institutions / Deerfield Management Company, L.P. / Activity
Activity — Deerfield Management Company, L.P.
15 moves.
| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Q1 2026 as of | Add | Xenon Pharmaceuticals Inc. Common stock | $62.43M | +1.1M +198.09% | 1,615,696 1.40% of portfolio | high |
| Q1 2026 as of | Add | Inspire Medical Systems, Inc. Common stock | $61.76M | +1.2M +79.51% | 2,703,238 2.08% of portfolio | high |
| Q1 2026 as of | Add | LEGN Legend Biotech Corp ADR | $31.76M | +1.8M +29.60% | 7,687,638 2.07% of portfolio | medium |
| Q1 2026 as of | Add | Tango Therapeutics, Inc. Common stock | $25.94M | +1.2M +42.65% | 4,146,813 1.29% of portfolio | medium |
| Q1 2026 as of | Add | Larimar Therapeutics, Inc. Common stock | $22.50M | +5.0M +16.34% | 35,606,974 2.39% of portfolio | medium |
| Q1 2026 as of | Add | Praxis Precision Medicines, Inc. Common stock | $19.33M | +60K +6.64% | 963,351 4.63% of portfolio | medium |
| Q1 2026 as of | Add | United Therapeutics Corp Common stock | $18.39M | +31K +7.28% | 457,000 4.04% of portfolio | medium |
| Q1 2026 as of | Add | BLTE Belite Bio, Inc ADR | $11.19M | +70K +30.02% | 304,013 0.72% of portfolio | medium |
| Q1 2026 as of | Add | IRON Disc Medicine, Inc. Common Stock | $9.32M | +146K +28.53% | 657,000 0.63% of portfolio | medium |
| Q1 2026 as of | Add | MNPR Monopar Therapeutics Inc. Common Stock | $8.39M | +153K +89.82% | 323,745 0.26% of portfolio | medium |
| Q1 2026 as of | Add | Biocryst Pharmaceuticals Inc Common stock | $6.64M | +697K +4.86% | 15,038,000 2.13% of portfolio | medium |
| Q1 2026 as of | Add | Beta Bionics, Inc. Common stock | $3.86M | +386K +41.11% | 1,324,000 0.20% of portfolio | low |
| Q1 2026 as of | Add | Foghorn Therapeutics Inc. Common stock | $3.56M | +745K +20.42% | 4,394,367 0.31% of portfolio | low |
| Q1 2026 as of | Add | N62509109 Common stock | $3.20M | +100K +2.40% | 4,264,789 2.03% of portfolio | low |
| Q1 2026 as of | Add | PHGE BiomX Inc. Common Stock | $8 | +2 +<0.01% | 131,272 <0.01% of portfolio | low |